Protara Therapeutics Inc (TARA)
2.89
-0.02
(-0.69%)
USD |
NASDAQ |
May 06, 16:00
2.91
+0.02
(+0.69%)
After-Hours: 20:00
Protara Therapeutics Total Liabilities (Quarterly): 9.728M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.728M |
| December 31, 2023 | 10.63M |
| September 30, 2023 | 11.51M |
| June 30, 2023 | 9.916M |
| March 31, 2023 | 11.64M |
| December 31, 2022 | 11.21M |
| September 30, 2022 | 9.413M |
| June 30, 2022 | 9.426M |
| March 31, 2022 | 9.021M |
| December 31, 2021 | 10.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 10.29M |
| June 30, 2021 | 10.49M |
| March 31, 2021 | 4.287M |
| December 31, 2020 | 3.914M |
| September 30, 2020 | 4.282M |
| June 30, 2020 | 3.825M |
| March 31, 2020 | 5.354M |
| December 31, 2019 | 3.351M |
| September 30, 2019 | 0.739M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.739M
Minimum
Sep 2019
11.64M
Maximum
Mar 2023
7.879M
Average
9.426M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| AngioDynamics Inc | 106.14M |
| Regulus Therapeutics Inc | 9.563M |
| Bio-Path Holdings Inc | 2.779M |
| Outset Medical Inc | 190.92M |
| AN2 Therapeutics Inc | 14.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.13M |
| Shareholders Equity (Quarterly) | 58.41M |